News

Parse Biosciences Releases Whole Transcriptome Version 2 Chemistry with Marked Performance Enhancements

Newly released Evercode™ Whole Transcriptome v2 kits have demonstrably improved gene detection and robustness. SEATTLE, August 30, 2022 –  Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today a significant performance update of its chemistry for the Evercode™ Whole Transcriptome products.  With substantial gains in transcript and gene detection […]

Read More

Parse Biosciences Announces Partnership with Molecular Diagnostics Korea

With products now available in South Korea, partnership broadens access to single cell genomics research in Asia Seattle, WA. (June 6, 2022) – Parse Biosciences, a leading provider of scalable single-cell sequencing solutions, today announced a partnership with Molecular Diagnostics Korea (MDxK) that will expand its presence in Asia by providing its entire line of […]

Read More

Parse Biosciences Announces Partnership With Research Instruments Group to Offer scRNA-Seq Kits in Singapore and Southeast Asia Region

Previously available in North America, Europe, Australia and New Zealand, partnership to further accelerate single cell genomics research in the APAC region Seattle, WA, January 18, 2022 Parse Biosciences, a company providing researchers with single-cell sequencing solutions, today announced a partnership with Research Instruments Pte Ltd to provide Parse’s Evercode Whole Transcriptome Kits (WTKs), Cell Fixation Kits […]

Read More

Parse Biosciences Unveils 1,000,000 Cell scRNA-seq Kit

The Evercode Whole Transcriptome Mega represents the most scalable and highest resolution single-cell platform to date Seattle, WA, October 20, 2021 Today at the annual American Society for Human Genetics meeting, Parse Biosciences, a company providing researchers with single-cell sequencing solutions, announced the launch of the most scalable single-cell RNA-seq solution on the market.  The Evercode […]

Read More